EFFEX® Tribulus (EFFAX® Tribulus)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceTribulus herb extractsTribulus herb extracts
Similar drugsTo uncover
  • Tribestan®
    pills inwards 
    Sopharma, AO     Bulgaria
  • EFFEX® Tribulus
    pills inwards 
    EVALAR, CJSC     Russia
    • Dosage form: & nbspfilm-coated tablets
    Composition:

    Composition per one tablet
    Active component: cropland herbs dry extract (35 + 45: 1, extractant ethyl alcohol 70%) with the content of the sum of furostanol saponins in terms of protodioscin and dry matter 45% - 250.0 mg.
    Auxiliary components: lactose - 228.0 mg, potato starch - 55.2 mg, microcrystalline cellulose - 50.8 mg, povidone K17 - 39.1 mg, crospovidone - 34.5 mg, talcum - 20.7 mg, silicon dioxide colloid - 6.9 mg, calcium stearate - 4.8 mg. Auxiliary components of the membrane: hypromellose (hydroxypropylmethylcellulose) - 15.17 mg, macrogol-400 (polyethylene glycol 400) - 4.55 mg, iron dye red oxide - 2.12 mg, titanium dioxide 1.52 mg, polysorbate 80 , 76 mg, ferric oxide black oxide - 0.58 mg, talc - 0.30 mg.

    Description:

    Tablets are round, biconvex, covered with a film shell of brown color; on the cross-section of a light brown color, it is allowed the presence of inclusions of brown, white and yellowish white color.

    Pharmacotherapeutic group:Means of plant origin
    ATX: & nbsp

    C.10.A.X   Other lipid-lowering drugs

    Pharmacodynamics:

    EFFEX® Tribulus is a plant-derived product derived from the overground part of the crooks of creeping (Tribulus terrestris L.), contains mostly steroid saponins of furostanol type. It has a general tonic effect and stimulates some functions of the reproductive system. In men, restores and improves sexual libido, lengthening the time of erection. Stimulates spermatogenesis, increasing the number of spermatozoa and their mobility. The mechanism of action of anchors of the creeping extract is unknown. It is assumed that the predominant protodioscin compound is metabolized in the body to dehydroepiandrosterone (DHEA), which has a beneficial effect on the immunity, integrity of the cell membrane, erectile function and cholesterol metabolism. It is known that cholesterol is the starting material for the synthesis of all steroids, inclusive DHEA, testosterone and estradiol, which explains the hypolipidemic effect of the drug. Other active furostanol saponins that are part of the crooks of the creeping extract are likely to modulate the protodioscin effect. The drug has a hypolipidemic effect,and in patients with lipoproteinemia reduces total cholesterol and low-density lipoproteins, does not affect the values ​​of serum triglycerides and high-density lipoproteins.

    Pharmacokinetics:

    Pharmacological studies in humans have not been conducted. Tribulus herb extracts dry contains a complex of biologically active substances, in connection with which the conduct of pharmacokinetic studies is not possible.

    Indications:

    The drug is used in complex therapy with:

    - Erectile dysfunction, including those accompanied by a decrease in libido;

    - infertility in men, due to idiopathic oligoasthenoteratozoospermia (reduction of the quantity and quality of spermatozoa in the isolated semen), surgical intervention for varicocele (varicose veins of the testicle of the testicle), immunological infertility;

    - Dyslipidemia for lowering the level of total cholesterol.

    Contraindications:

    Hypersensitivity to all components of the drug.

    Hyperplasia of the prostate.

    Severe cardiovascular diseases (stroke, myocardial infarction during the past year or severe,unstable and uncontrolled cardiovascular diseases (unstable angina, chronic heart failure with symptoms at rest, sinus node weakness syndrome, or conduction disorders such as the sinoatrial block, atrioventricular block II or III degree, bradycardia <50 beats / min), and kidney disease (severe renal insufficiency (creatinine clearance <25 ml / min or creatinine> 180 μmol / l).

    Galactosemia, Lactase Lactate Deficiency, or Glucose-Galactose Malabsorption Syndrome.

    Pregnancy and the period of breastfeeding.

    Age to 18 years.

    Carefully:

    Patients with diabetes mellitus.

    Pregnancy and lactation:

    The use of the drug is not recommended during pregnancy and during breastfeeding.

    Dosing and Administration:

    Inside, after eating.

    With erectile dysfunction and infertility: 1-2 tablets 3 times a day.

    Duration of treatment is not less than 90 days. The course of treatment can be repeated on the recommendation of a doctor.

    With dyslipidemia to reduce the level of total cholesterol: 2 tablets 3 times a day. Course - not less than 3 months. Repeated courses - on the advice of a doctor.

    Side effects:

    Allergic reactions are possible. Irritant effect on the gastric mucosa (nausea).

    In case of side effects, including those not described in the instructions, you should consult your doctor.

    Overdose:

    There are no reports of cases of drug overdose. When using the drug in doses exceeding the recommended, there may be dyspeptic disorders (nausea, vomiting). Treatment is symptomatic.

    Interaction:

    The drug can enhance the action of diuretics and potentiate the antihypertensive effect of antihypertensive agents.

    Special instructions:

    Before you start taking the drug, you should consult your doctor.

    If there is no effect on the background of taking the drug within 1 month, you should consult a doctor. To avoid possible irritant effects of the drug on the gastric mucosa, it is recommended to take the drug after eating. Patients suffering from diabetes should take into account that each tablet contains lactose and starch. The drug should not be administered to patients with galactosemia, Lappease lactase deficiency, or glucose-galactose malabsorption syndrome.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to perform potentially dangerous activities requiring increased concentration and speed of psychomotor reactions (vehicle management, work with moving mechanisms, dispatcher and operator work).

    Form release / dosage:

    Tablets, film-coated, 250 mg.

    Packaging:

    For 60, 90 or 180 tablets in a can of polymer. For 15 tablets in a contour mesh package made of a polyvinylchloride film and flexible packaging made on the basis of aluminum foil. For 4 or 6 contour mesh packages, or each jar, together with the instruction for use, is placed in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-004200
    Date of registration:17.03.2017
    Expiration Date:17.03.2022
    The owner of the registration certificate:EVALAR, CJSC EVALAR, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp13.04.2017
    Illustrated instructions
      Instructions
      Up